Yenidoğan Döneminde Sık Karşılaşılan Kardiyak Sorunlar
Özet
Hayatın ilk 28 günü yenidoğan dönemi olarak adlandırılmaktadır. Bu dönem, fetal dolaşımdan postnatal dolaşıma geçişin yaşandığı ve fizyolojik adaptasyonun en yoğun olduğu süreçtir. Doğumdan sonra özellikle dolaşım ve solunum sistemleri, hayati fonksiyonların sorumluluğunu devralır. Bu süreçte ortaya çıkan kardiyak sorunlar; hafif seyirli fonksiyonel bozukluklardan, acil cerrahi müdahale gerektiren ağır yapısal anomalilere kadar geniş bir yelpazede çeşitlilik gösterir. Kritik konjenital kalp hastalıkları, bazı ritim bozuklukları ve özellikle prematüre bebeklerde sorun oluşturan patent duktus arteriozus, bu dönemde sık karşılaşılan kardiyak sorunlardır. Neonatal dönemde geç tanı aldığında veya uygun müdahaleler yapılmadığında ağır komplikasyonlarla, hatta mortaliteyle sonuçlanabilecek bu tür kardiyak rahatsızlıkların sağlık çalışanları tarafından erken dönemde tanınması ve gerekli tedavilerin en kısa sürede başlatılması, gelişebilecek mortalite ve morbiditeyi önlemek açısından kritik önem taşımaktadır.
The first 28 days of life are defined as the neonatal period. This period represents a critical phase characterized by intense physiological adaptation, during which the transition from fetal to postnatal circulation occurs. Following birth, the circulatory and respiratory systems, in particular, assume responsibility for vital functions. Cardiac problems arising during this period encompass a wide spectrum, ranging from mild functional disorders to severe structural anomalies that require emergency surgical intervention. Critical congenital heart diseases, arrhythmias, and patent ductus arteriosus which predominantly poses a challenge in preterm infants are among the frequently encountered cardiac issues in this period. These cardiac disorders can lead to severe complications or even mortality if diagnosed late or managed inadequately during the neonatal period. Therefore, early recognition of these conditions by healthcare professionals and the prompt initiation of appropriate treatments are of paramount importance in preventing potential mortality and morbidity.
Referanslar
Morton SU, Brodsky D. Fetal Physiology and the Transition to Extrauterine Life. Clin Perinatol. 2016; 43(3): 395–407. doi: 10.1016/j.clp.2016.04.001.
Cavaliere TA. From Fetus to Neonate: A Sensational Journey. Newborn Infant Nurs Rev. 2016; 16(2): 43–7. doi.org/10.1053/j.nainr.2016.03.004
Tan CMJ, Lewandowski AJ. The Transitional Heart: From Early Embryonic and Fetal Development to Neonatal Life. Fetal Diagn Ther. 2020;47(5):373-86. doi: 10.1159/000501906.
Jain A, Mohamed A, Kavanagh B, et al. Cardiopulmonary Adaptation During First Day of Life in Human Neonates. J Pediatr. 2018;200: 50–7. doi: 10.1016/j.jpeds.2018.04.051.
Kabbani N, Kabbani MS, Al Taweel H. Cardiac emergencies in neonates and young infants. Avicenna J Med 2017;7:1-6. doi: 10.4103/2231-0770.197506.
Kelly RG, Buckingham ME, Moorman AF. Heart fields and cardiac morphogenesis. Cold Spring Harb Perspect Med. 2014 ;4(10):a015750. doi: 10.1101/cshperspect.a015750.
Huang JB, Liu YL, Lv XD. Pathogenic mechanisms of congenital heart disease. Fetal and pediatric pathology. 2010; 29:359–72. doi: 10.3109/15513811003789628.
Gittenberger-de Groot AC, Bartelings MM, Poelmann RE, et al. Embryology of the heart and its impact on understanding fetal and neonatal heart disease. Semin Fetal Neonatal Med 2013;18(5):237–44. doi: 10.1016/j.siny.2013.04.008
Finnemore A, Groves A. Physiology of the fetal and transitional circulation. Semin Fetal Neonatal Med. 2015 ; 20(4): 210–6. doi: 10.1016/j.siny.2015.04.003.
Park MK. Salamat M. Fetal and Perinatal Circulation. Park’s Pediatric Cardiology for Practitioners. 7th ed. Philadelphia ; 2021:92-5
Gupta A, Paria A. Transition from fetus to neonate. Surgery. 2016; 34(12): 593–6.
Kavgacı A, Tunaoğlu FS. Fötal ve neonatal dolaşım. Oğuz AD, editör. Yenidoğan Kardiyolojik Sorunlarına Yaklaşım. 1. Baskı. Ankara: Türkiye Klinikleri; 2022:1-9.
Sharma A, Ford S, Calvert J. Adaptation for life: a review of neonatal physiology. Anaesth Intensive Care Med. 2014; 15(3): 89– 95. doi.org/10.1016/j.mpaic.2014.01.002
Gill AW. Postnatal cardiovascular adaptation. Arch Dis Child Fetal Neonatal Ed. 2019;104(2):220-4. doi: 10.1136/archdischild-2017-314453.
Rios DR, Bhattacharya S, Levy PT, McNamara PJ. Circulatory insufficiency and hypotension related to the ductus arteriosus in neonates. Front Pediatr. 2018;15 (6): 62. doi: 10.3389/fped.2018.00062.
Tsao PC, Shiau YS, Chiang SH et al. Development of a newborn screening program for critical congenital heart disease (CCHD) in Taipei. PLoS One 2016;11(4):e0153407. doi: 10.1371/journal.pone.0153407.
Garcia RU, Peddy SB. Heart Disease in Children. Primary Care: Clinics in Office Practice, 2018;45(1):143-54. doi: 10.1016/j.pop.2017.10.005.
Lindinger A, Schwedler G, Hense HW. Prevalence of congenital heart defects in newborns in Germany: Results of the first registration year of the PAN Study (July 2006 to June 2007). Klin Padiatr 2010; 222: 321- 6. doi: 10.1055/s-0030-1254155.
Schultz AH, Localio AR, Clark BJ. et al. Epidemiologic features of the presentation of critical congenital heart disease: implications for screening. Pediatrics 2008; 121: 751 – 7. doi: 10.1542/peds.2007-0421.
T.C. Sağlık Bakanlığı Neonatal Kritik Doğumsal Kalp Hastalıkları Tarama Rehberi (2021).
Böhne M, Jack T, Köditz H, Beerbaum P. Kritische Herzfehler des Neugeborenen Teil 1: Grundlagen, Diagnostik und allgemeine Therapieprinzipien Neonatologie Scan 2015; 04(01): 61-88. doi: 10.1055/s-0034-1391489
Dittrich S, Glöckler M. Neonatale Kardiologie Frauenheilkunde up2date 2011; 5(1): 61–72.
Qiu X, Weng Z, Liu M. et al. Prenatal diagnosis and pregnancy outcomes of 1492 fetuses with congenital heart disease: role of multidisciplinary-joint consultation in prenatal diagnosis. Sci Rep. 2020;10(1):7564. doi: 10.1038/s41598-020-64591-3
Ma X, Tian Y, Ma F, et al. Impact of newborn screening programme for congenital heart disease in Shanghai: a five-year observational study in 801,831 newborns. Lancet Reg Health West Pac. 2023;33:100688.
Seale AN, Carvalho JS, Gardiner HM. et al. Total anomalous pulmonary venous connection: impact of prenatal diagnosis. Ultrasound Obstet Gynecol 2012;40: 310-8. doi: 10.1002/uog.11093.
Punn R, Silverman NH. Fetal predictors of urgent balloon atrial septostomy in neonates with complete transposition. J Am Soc Echocardiogr 2011;24: 425-30. doi: 10.1016/j.echo.2010.12.020.
Pruetz JD, Wang SS, Noori S. Delivery room emergencies in critical congenital heart diseases. Semin Fetal Neonatal Med. 2019;24(6):101034. doi: 10.1016/j.siny.2019.101034.
Johnson BA, Ades A. Delivery room and early postnatal management of neonates who have prenatally diagnosed congenital heart disease. Clin Perinatol 2005; 32(4): 921-46. doi: 10.1016/j.clp.2005.09.014.
Kovacevic A, Simmelbauer A, Starystach S. et al. Counseling for prenatal congenital heart disease-recommendations based on empirical assessment of counseling success. Front Pediatr. 2020;8:26. doi: 10.3389/fped.2020.00026
Henderson A, Aguirre D, Singh A, Ewer AK. Temporal trends in routine predischarge pulse oximetry screening: 6 years' experience in a UK regional neonatal unit. Arch Dis Child Fetal Neonatal Ed. 2022 ;107(3):256-61. doi: 10.1136/archdischild-2021-322303.
Çaylan N, Yalçın SS, Tezel B. et al. Evaluation of critical congenital heart disease from 2018 to 2020 in Turkey: a retrospective cohort study. BMC Pregnancy Childbirth. 2023 16;23(1):871.
Terlemez S. Yenidoğanda pals oksimetre tarama testi. Oğuz AD, editör. Yenidoğan Kardiyolojik Sorunlarına Yaklaşım. 1. Baskı. Ankara: Türkiye Klinikleri; 2022:17-21.
Singh Y, Chen SE. Impact of pulse oximetry screening to detect congenital heart defects: 5 years' experience in a UK regional neonatal unit. Eur J Pediatr. 2022;181(2):813-21. doi: 10.1007/s00431-021-04275-w.
Jawin V, Ang HL, Omar A, Thong MK. Beyond Critical Congenital Heart Disease: Newborn Screening Using Pulse Oximetry for Neonatal Sepsis and Respiratory Diseases in a Middle-Income Country. PLoS One. 2015;10(9):e0137580. doi: 10.1371/journal.pone.0137580.
Sharma M, Sasikumar M, Karloopia SD, Shahi BN. Prostaglandins in congenital heart disease. Med J Armed Forces India. 2011;57(2):134–8. doi: 10.1016/S0377-1237(01)80134-9.
Taksande A, Jameel PZ. Critical Congenital Heart Disease in Neonates: A Review Article. Curr Pediatr Rev. 2021;17(2):120-6. doi: 10.2174/1573396317666210219162515.
Desai K, Rabinowitz EJ, Epstein S. Physiologic diagnosis of congenital heart disease in cyanotic neonates. Curr Opin Pediatr. 2019;31(2):274-83. doi: 10.1097/MOP.0000000000000742
Khalil M, Jux C, Rueblinger L, Behrje J, Esmaeili A, Schranz D. Acute therapy of newborns with critical congenital heart disease. Transl Pediatr. 2019 ;8(2):114-26. doi: 10.21037/tp.2019.04.06.
Mellander M. Diagnosis and management of life-threatening cardiac malformations in the newborn. Semin Fetal Neonatal Med. 2013;18(5):302-10. doi: 10.1016/j.siny.2013.04.007.
Yıldırım Aİ, Türkmen Karaağaç A. Duktus bağımlı siyanotik kalp hastalıkları. Oğuz AD, editör. Yenidoğan Kardiyolojik Sorunlarına Yaklaşım. 1. Baskı. Ankara: Türkiye Klinikleri; 2022:46-53
Wheeler CR, Sen S, Levy PT. The ductus arteriosus in neonates with critical congenital heart disease. J Perinatol. 2022;42(12):1708-13. doi: 10.1038/s41372-022-01449-8.
Atasayan V. Siyanotik yenidoğana yaklaşım. Oğuz AD, editör. Yenidoğan Kardiyolojik
Sorunlarına Yaklaşım. 1. Baskı. Ankara: Türkiye Klinikleri; 2022:40-5.
Albrecht GT. Cardiogenic shock in the neonate. Indian J Pediatr 1993;60(3):381 91. doi: 10.1007/BF02751199.
Kavgacı A, Kula S. Normal yenidoğanın kardiyovasküler sistem fizik muayene bulguları ve temel tetkikler. Oğuz AD, editör. Yenidoğan Kardiyolojik Sorunlarına Yaklaşım. 1. Baskı. 2 Ankara: Türkiye Klinikleri; 2022:10-6.
Hoffman GM, Tweddell JS, Ghanayem NS, et al. Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the Norwood procedure. J Thorac Cardiovasc Surg 2004;127(3):738-45.doi: 10.1016/s0022-5223(03)01315-1.
Yogen Singh, Diagnosis and management of critical congenital heart defects in infants, Paediatrics and Child Health 2022;32(9):332-8. doi.org/10.1016/j.paed.2022.07.003
Gomella’s Management, Procedures, On-Call Problems, Diseases and Drugs 8th. Edition Editor Tricia Lacy Gomella, Fabien Eyal and Fayez Bany-Mohammed . Patent Ductus Arteriosus: 2020; 1027-31.
Gentile R, Stevenson G, Dooley T.et al. Pulsed Doppler echocardiographic determination of time of ductal closure in normal newborn infants. J Pediatr. 1981;98(3):443–8. doi: 10.1016/s0022-3476(81)80719-6.
De Klerk JCA, Engbers AGJ, vanBeek F, et al. Spontaneous Closure of the Ductus Arteriosus in Preterm Infants: A Systematic Review. Front Pediatr. 2020; 8: 541. doi: 10.3389/fped.2020.00541
Elsayed YN, Fraser D. Patent ductus arteriosus in preterm infants, Part 1: understanding the pathophysiologic link between the patent ductus arteriosus and clinical complications. Neonatal Netw. 2017;36(5):265–72. doi: 10.1891/0730-0832.36.5.265.
Noori S, Mc Coy M, Friedlich P.et al. Failure of ductus arteriosus closure is associated with increased mortality in preterm infants. Pediatrics. 2009;123(1):138-44. doi: 10.1542/peds.2008-2418.
Ciuffreda M, Ferrero P. Pervietà del dotto arterioso [Patent ductus arteriosus]. G Ital Cardiol (Rome). 2015 ;16(4):232-9. doi: 10.1714/1848.20188.
Koch J, Hensley G, Roy L. Et al. Prevalence of spontaneous closure of the ductus arteriosus in neonates at a birth weight of 1000 grams or less. Pediatrics. 2006;117(4):1113–21. doi: 10.1542/peds.2005-1528
Benitz WE. Committee on Fetus and Newborn, American Academy of Pediatrics. Patent Ductus Arteriosus in Preterm ınfants. Pediatrics. 2016;137(1) e20153730. doi:10.1542/peds.2015-3730
Ovali F. Molecular and mechanical mechanisms regulating ductus arteriosus closure in preterm infants. Front Pediatr. 2020;8:516. doi: 10.3389/fped.2020.00516.
Kim ES, Kim EK, Choi CW, et al. Intrauterine inflammation as a risk factor for persistent ductus arteriosus patency after cyclooxygenase inhibition in extremely low birth weight infants. J Pediatr. 2010;157:745–50. doi: 10.1016/j.jpeds.2010.05.020.
Benitz WE , Bhombal S .Patent Ducutus Arteriosus . Fanaroff and Martin’s Neonatal-Perinatal Medicine 12th EditionVols I and II Richard J. Martin, Avroy A. Fanaroff. Elsevier:2024:1402-1410
Lee JA, Sohn JA, Oh S, Choi BM. Perinatal risk factors of symptomatic preterm patent ductus arteriosus and secondary ligation. Pediatr Neonatol. 2020;61(4):439–46. doi: 10.1016/j.pedneo.2020.03.016.
Sehgal A, Paul E, Menahem S. Functional echocardiography in staging for ductal disease severity: role in predicting outcomes. Eur J Pediatr. 2013;172(2):179–84. doi: 10.1007/s00431-012-1851-0.
Öncel MY. Prematür bebeklerde patent duktus arteriozus ve medikal tedavisi. Narin N, editör. Prematür Patent Duktus Arteriozus Yönetimi. 1. Baskı. Ankara: Türkiye Klinikleri; 2021:22-9.
Güven B. Prematür bebeklerde patent duktus arteriozus ne zaman kapatılmalı? Narin N, editör. Prematür Patent Duktus Arteriozus Yönetimi. 1. Baskı. Ankara: Türkiye Klinikleri;
2021:18-21.
Fink D, El-Khuffash A, McNamara PJ, Nitzan I,Hammerman C. Tale of two patent ductus arteriosus severity scores: similarities and differences. Am J Perinatol. 2018;35(1):55–8. doi: 10.1055/s-0037-1605576.
El-Khuffash A, James AT, Corcoran JD, et al. A patent ductus arteriosus severity score predicts chronic lung disease or death before discharge. J Pediatr. 2015;167(6):1354–61. doi: 10.1016/j.jpeds.2015.09.028.
Sellmer A, Hjortdal VE, Bjerre JV, et al. Cardiovascular biomarkers in the evaluation of patent ductus arteriosus in very preterm neonates: a cohort study. Early Hum Dev. 2020;149:105142. doi: 10.1016/j.earlhumdev.2020.105142.
Gokulakrishnan G, Kulkarni M, He S, et al. Brain natriuretic peptide and N-terminal brain natriuretic peptide for the diagnosis of haemodynamically significant patent ductus arteriosus in preterm neonates. Cochrane Database Syst Rev. 2022;12(12):013129. doi: 10.1002/14651858.CD013129.pub2
El-Khuffash AF, Slevin M, McNamara PJ, et al. N-terminal pro natriuretic peptide and a patent ductus arteriosus scoring system predict death before discharge or neurodevelopmental outcome at 2 years in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2011;96(2):133–7. doi: 10.1136/adc.2010.185967.
Köksal N, Aygün C, Uras N. Turkish Neonatal Society guideline on the management of patent ductus arteriosus in preterm infants. Turk Pediatri Ars. 2018; 53(1):76-87. doi: 10.5152/TurkPediatriArs.2018.01808.
Therrien, J. Webb GD. Congenital heart disease in adults. In: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. Philadelphia: Saunders, 2001:589- 62.
Vanhaesebrouck S, Zonnenberg I, Vandervoort P, et al. Conservative treatment for patent ductus arteriosus in the preterm. Arch Dis Child Fetal Neonatal Ed. 2007;92(4):244–47. doi: 10.1136/adc.2006.104596.
Srajer A, Roychoudhury S, Tang S, et al. Postnatal acetaminophen exposure and neurodevelopmental outcomes at 18–21 months corrected gestational age in preterm infants <29 weeks gestation: a retrospective cohort study. Pediatr Res. 2024;96(2):388-94. doi: 10.1038/s41390-023-02901-x.
Hirano S, Fujimura M, Kusuda S, et al. Randomized control trial for the prevention of intraventricular hemorrhage and patent ductus arteriosus by indomethacin in Japanese extremely low birth weight infants. Jpn J Dev Pharmacol Ther. 2007;20:98–102.
Potsiurko S, Dobryanskyy D, Sekretar L, Salabay Z. Randomized Noninferiority Trial of Expectant Management versus Early Treatment of Patent Ductus Arteriosus in Preterm Infants. Am J Perinatol. 2024 ;41(6):730-38. doi: 10.1055/a-1782-5860.
Gudmundsdottir A, Johansson S, Hakansson S, et al. Timing of pharmacological treatment for patent ductus arteriosus and risk of secondary surgery, death or bronchopulmonary dysplasia: a population-based cohort study of extremely preterm infants. Neonatology. 2015;107(2):87–92. doi: 10.1159/000367887.
Hagadorn JI, Shaffer ML, Tolia VN, Greenberg RG. Covariation of changing patent ductus arteriosus management and preterm infant outcomes in Pediatrix neonatal intensive care units. J Perinatol. 2021;41(10):2526–31. doi: 10.1038/ s41372-021-01170-y
Smith A, McNamara PJ, El-Khuffash AF. Non-pharmacological management of a hemodynamically significant patent ductus arteriosus. Semin Fetal Neonatal Med. 2018;23(4):245–49. doi: 10.1016/j.siny.2018.03.008
van der Lugt NM, Lopriore E, Bokenkamp R, et al. Repeated courses of ibuprofen are effective in closure of a patent ductus arteriosus. Eur J Pediatr. 2012;171(11):1673–77. doi: 10.1007/s00431-012-1805-6.
Mitra S, de Boode WP, Weisz DE, Shah PS. Interventions for patent ductus arteriosus (PDA) in preterm infants: an overview of Cochrane Systematic Reviews. Cochrane Database Syst Rev. 2023;4(4):013588. doi: 10.1002/14651858.CD013588
S.Mitra, Florez ID, Tamayoet ME et al. Association of placebo, indomethacin, ibuprofen, and acetaminophen with closure of hemodynamically significant patent ductus arteriosus in preterm infants: a systematic review and meta-analysis JAMA, 2018;319(12):1221-38. doi: 10.1001/jama.2018.1896.
M. Kluckow, Jeffery M, Gill A, Evans N. A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus Arch Dis Child Fetal Neonatal Ed. 2014;99(2):99-104. doi: 10.1136/archdischild-2013-304695
C. Hammerman, Bin-Nun A, Abdaljalil H. et al. Dual therapy vs. monotherapy for the patent ductus arteriosus: a systematic review Pediatr Cardiol.2022;43(5):935-42. doi: 10.1007/s00246-022-02888-y.
Kuntz MT, Staffa SJ, Graham D, et al. Trend and Outcomes for Surgical Versus Transcatheter Patent Ductus Arteriosus Closure in Neonates and Infants at US Children’s Hospitals. J Am Heart Assoc. 2022;11(1):022776. doi: 10.1161/JAHA.121.022776
Jaeggi E, Öhman A. Fetal and neonatal arrhythmias. Clin Perinatol. 2016; 43(1):99-112. doi:10.1016/j.clp.2015.11.007
Kundak AA, Dilli D, Karagol B. et al. Non benign neonatal arrhythmias observed in a tertiary neonatal intensive care unit. Indian J Pediatr 2013;80(7):555-9. doi: 10.1007/s12098-012-0852-3.
Picchio FM, Prandstraller D, Bronzetti G, Cervi E. Follow-up of neonates with foetal and neonatal arrhythmias. J Matern Fetal Neonatal Med. 2012; 25(4):53. doi:10.3109/14 767058.2012.714980
Ban JE. Neonatal arrhythmias: Diagnosis, treatment, and clinical outcome. Korean J Pediatr. 2017; 60(11):344-52. doi: 10.3345/kjp.2017.60.11.344.
Uusitalo A, Tikkakoski A, Reinikainen M, et al. Extrasystoles or short bradycardias of the newborn seldom require subsequent 24 hour electrocardiographic monitoring. Acta Paediatr. 2022;111(5):979–84. doi: 10.1111/apa.16259.
Mejia E, Hoyt W, Snyder CS. Symptomatic atrial bigeminy masquerading as congenital complete heart block. Cardiol Young. 2022;32(5):830-2. doi: 10.1017/S104795112100384X.
Cannon B, SynderS. C. Disoerders of cardiac Rhythm and Conduction in Newborn. Fanaroff and Martin’s Neonatal-Perinatal Medicine 12th EditionVols I and II Richard J. Martin, Avroy A. Fanaroff. Elsevier:2024: 1452-69.
Wren C. Cardiac arrhythmias in the fetus and newborn. Semin Fetal Neonatal Med 2006;11(3):182-90. doi: 10.1016/j.siny.2005.12.001.
Refaat M, Abohelwa MM, Ahmed M. et al. Arrhythmias in neonates and infants at a tertiary care center. Cureus. 2021;13(1):12861. doi:10.7759/cureus.12861
Nagashima M, Matsushima M, Ogawa A. et al. Cardiac arrhythmias in healthy children revealed by 24-hour ambulatory ECG monitoring. Pediatr Cardiol 1987;8(2):103-8. doi: 10.1007/BF02079464.
De Rosa G, Butera G, Chessa M, et al. Outcome of newborns with asymptomatic monomorphic ventricular arrhythmia. Archives of Disease in Childhood - Fetal and Neonatal Edition 2006;91(6):419–22. doi: 10.1136/adc.2005.092932.
Kaya Çelebi S, Özgür S. Yenidoğan döneminde supraventriküler taşikardiler. Oğuz AD, editör. Yenidoğan Kardiyolojik Sorunlarına Yaklaşım. 1. Baskı. Ankara: Türkiye Klinikleri. 2022:65-71.
Southall DP, Richards J, Mitchell P. et al. Study of cardiac rhythm in healthy newborn infants. Br Heart J. 1980;43(1):14-20. . doi: 10.1136/hrt.43.1.14.
Kantoch MJ. Supraventricular tachycardia in children. Indian J Pediatr. 2005; 72(7):609–19. doi: 10.1007/BF02724188.
Qi J, Yu R, Wang X. Neonatal supraventricular tachycardia: current diagnostic approaches and emerging technologies. Front. Pediatr. 2026; 13:1694215. doi: 10.3389/fped.2025.1694215
Kafali HC, Ergul Y. Common supraventricular and ventricular arrhythmias in children. Turkish Archives of Pediatrics. 2022;57(5):476–88. doi: 10.5152/TurkArchPediatr.2022.22099.
Ko JK, Deal BJ, Strasburger JF, Benson DW. Supraventricular tachycardia mechanisms and their age distribution in pediatric patients. Am J Cardiol. 1992; 69(12):1028–32. doi: 10.1016/0002-9149(92)90858-v.
Rutledge J, Bricker JT. Congenital Diseases of the Heart: Clinical-Physiological Considerations (Fully Revised and Updated Second Edition). Tex Heart Inst J. 2001;28(3):237.
Jimenez E, El-Bokl A, Aggarwal V, Cortez D. Catheter ablation of atrioventricular nodal reentrant tachycardia, when AVNRT presented as a fetus or infant. Pacing Clin Electrophysiol. 2023; 46(11):1310–4. doi: 10.1111/pace.14833.
Joana SR, Mariana C, Ana C, et al. Neonatal Supraventricular Tachycardia – A Diagnostic Challenge. J Pediatr Neonatal. 2021; 3(1): 1-3.
Salerno JC, Kertesz NJ, Friedman RA, Fenrich Jr AL. Clinical course of atrial ectopic tachycardia is age-dependent: results and treatment in children < 3 or > or =3 years of age. J Am Coll Cardiol. 2004; 43(3):438–44. doi: 10.1016/j.jacc.2003.09.031.
Kline J, Costantini O. Arrhythmias in congenital heart disease. Med Clin North Am. 2019;103(5):945–56. doi: 10.1016/j.mcna.2019.04.007.
Garud B, Kumar G, Chavan S, Salunk S, Reddy GC. Unexpected rhythm: supraventricular tachycardia unveiled in a neonate diagnosed at delivery. Cureus. 2024;16(7):e65710. doi: 10.7759/cureus.65710.
Guerrier K, Shamszad P, Czosek RJ, Spar DS, Knilans TK, Anderson JB. variation in antiarrhythmic management of infants hospitalized with supraventricular tachycardia: a multi-ınstitutional analysis. Pediatr Cardiol. 2016;37(5):946-52. doi: 10.1007/s00246-016-1375-x
Bolin EH, Lang SM, Tang X, Collins RT. Propranolol versus digoxin in the neonate for supraventricular tachycardia (from the pediatric health ınformation system). Am J Cardiol. 2017;119(10):1605-10. doi: 10.1016/j.amjcard.2017.02.017
Spearman AD, Williams P. Supraventricular Tachycardia in Infancy and Childhood. Pediatr Ann. 2014; 43(11): 456-60. doi: 10.3928/00904481-20141022-13.
Chu PY, Hill KD, Clark RH, Smith PB, Hornik CP. Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database. Early Hum Dev 2015;91(6):345–50. doi: 10.1016/j.earlhumdev.2015.04.001.
Mojahedi A, Mirshekari A. Evaluating antiarrhythmic drugs for managing infants with supraventricular tachycardia; a review. Am J Cardiovasc Dis. 2024; 14(3):144–52. doi: 10.62347/ZTXC5809.
